Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic nitrates in refractory normal tension glaucoma
2025-522059-24-00Phase 4Authorised
- Sponsor
- University of Helsinki
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of isosorbide mononitrate in normal tension glaucoma (NTG), sponsored by University of Helsinki. Primary endpoint: Change in retinal nerve fiber layer thickness. Planned start Nov 2025; status: authorised.
02
Drugs
isosorbide mononitrate
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on 2025-522059-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522059-24-00.